Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-12-28FDA Approved: TOPIRAMATE — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for Topiramate under ANDA 079162 for the generic product.
-
FDA approval · 2010-12-28FDA Approved: TOPIRAMATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the supplemental application for Topiramate submitted by Unichem Pharmaceuticals (USA), Inc., under ANDA090162.
-
FDA approval · 2010-12-23FDA Approved: TOPIRAMATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for TOPIRAMATE SPINKLE, a sprinkle formulation of topiramate manufactured by Heritage Pharmaceutical…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Conversion to Monotherapy Study With Keppra XR for Partial Seizures [Phase 3]
Phase 3 trial evaluating conversion to Keppra XR monotherapy for partial seizures in epilepsy; results from the completed study have been po…
-
FDA approval · 2010-12-17FDA Approved: GABAPENTIN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's Original Application for gabapentin (generic), authorizing its use for partial seizures in epilepsy …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-12-16Clinical Trial Update: Pharmacokinetics of Levetiracetam (Keppra) in Neonates
This clinical trial update describes the pharmacokinetics of levetiracetam (Keppra) in neonates to inform dosing for seizures/epilepsy. The …
-
FDA approval · 2010-12-15FDA Approved: LEVETIRACETAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for levetiracetam from Sun Pharmaceutical Industries, Inc., updating the approval status for this ge…
-
FDA approval · 2010-12-13FDA Approved: LEVETIRACETAM — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for levetiracetam submitted by BluePoint Laboratories, enabling the generic product’s approval.
-
FDA approval · 2010-12-13FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for levetiracetam from Aurobindo Pharma Limited, authorizing a generic Levetiracetam product under a…
-
FDA approval · 2010-11-30FDA Approved: PRIMIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for PRIMIDONE from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2010-11-30FDA Approved: PRIMIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for Primidone under the approved ANDA.
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Characterization of Epileptic Motor Patterns by Tridimensional Analysis of Movement 2 [NA]
The study evaluating tridimensional analysis of motor patterns in epileptic seizures was terminated; the update notes the status rather than…
-
FDA approval · 2010-11-17FDA Approved: LEVETIRACETAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for levetiracetam by Actavis Pharma, Inc., approving an updated generic product.
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of topiramate as monotherapy for recently diagnosed partial-onset seizures has complet…
-
FDA approval · 2010-11-04FDA Approved: LAMOTRIGINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for lamotrigine from Jubilant Cadista Pharmaceuticals Inc., indicating approved changes to labeling.
-
FDA approval · 2010-10-26FDA Approved: ZONISAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for zonisamide submitted by Sun Pharmaceutical Industries, Inc., indicating an approved update t…
-
FDA approval · 2010-10-25FDA Approved: LEVETIRACETAM SOLUTION — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application to add an oral solution form of levetiracetam (LEVETIRACETAM SOLUTION) manufactured by Chartwell…
-
FDA approval · 2010-10-24FDA Approved: LAMICTAL — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for Lamictal (lamotrigine) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2010-10-24FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for EQUETRO (carbamazepine) from Validus Pharmaceuticals LLC.
-
FDA approval · 2010-10-22FDA Approved: OXCARBAZEPINE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for oxcarbazepine submitted by Advagen Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures [Phase 3]
Phase 3 trial update reports safety findings for intravenous lacosamide followed by twice-daily oral lacosamide in adults with partial-onset…
-
FDA approval · 2010-10-11FDA Approved: CELONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for CELONTIN (methsuximide) submitted by Parke-Davis Div of Pfizer Inc.
-
FDA label_change · 2010-10-11FDA Approved: TIAGABINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for tiagabine hydrochloride, resulting in updated labeling for the product marketed by Teva Phar…
-
CLINICAL_TRIALS research · 2010-10-11Clinical Trial Update: Lamotrigine Pregnancy Registry (LAM05)
Update on the Lamotrigine Pregnancy Registry (LAM05) reporting results from pregnancy exposure data in epilepsy and bipolar disorder, sponso…
-
FDA approval · 2010-10-08FDA Approved: LEVETIRACETAM — Original Application (NorthStar RxLLC)
FDA approved a generic version of levetiracetam under an Original Application for NorthStar RxLLC.